Evidence map›Paper›PMID 40149275›Full record

ReviewCancers2025

Prognostic Significance of Key Molecular Markers in Thyroid Cancer: A Systematic Literature Review and Meta-Analysis.

Linh T T Nguyen, Emma K Thompson, Nazim Bhimani, Minh C Duong, Huy G Nguyen, Martyn Bullock, Matti L Gild, Anthony Glover

Erratum issuedAbstract readReview
In one paragraph

Review in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. The actual and future role of molecular tests in thyroid pathology.Virchows Archiv : an international journal of pathology · 2026
    Review
  8. Article
  9. Review
  10. Multi-gene co-mutations ofFrontiers in endocrinology · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Linh T T NguyenKolling Institute, Northern Sydney Local Health District and Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW 2050, Australia.
Emma K ThompsonThe Kinghorn Cancer Centre, Garvan Institute of Medical Research, St. Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Darlinghurst, NSW 2010, Australia.
Nazim BhimaniThe Kinghorn Cancer Centre, Garvan Institute of Medical Research, St. Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Darlinghurst, NSW 2010, Australia.ORCID 0000-0003-3995-4285
Minh C DuongSchool of Population Health, University of New South Wales, Sydney, NSW 2033, Australia.ORCID 0000-0002-9300-0047
Huy G NguyenSchool of Biomedical Engineering, University of Technology Sydney, Sydney, NSW 2007, Australia.ORCID 0000-0002-6545-7242
Martyn BullockKolling Institute, Northern Sydney Local Health District and Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW 2050, Australia.ORCID 0000-0002-3740-5509
Matti L GildKolling Institute, Northern Sydney Local Health District and Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW 2050, Australia.ORCID 0000-0002-6670-2254
Anthony GloverKolling Institute, Northern Sydney Local Health District and Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW 2050, Australia.ORCID 0000-0003-0762-0977

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BRAFmutationsPI3K pathwaysurvivalTERT promoterthyroid cancerTP53

Identifiers

PMID40149275
PMCPMC11940365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.